MX342226B - Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio. - Google Patents

Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio.

Info

Publication number
MX342226B
MX342226B MX2012011706A MX2012011706A MX342226B MX 342226 B MX342226 B MX 342226B MX 2012011706 A MX2012011706 A MX 2012011706A MX 2012011706 A MX2012011706 A MX 2012011706A MX 342226 B MX342226 B MX 342226B
Authority
MX
Mexico
Prior art keywords
treatment
streptococcus salivarius
respiratory tract
chronic infections
present
Prior art date
Application number
MX2012011706A
Other languages
English (en)
Other versions
MX2012011706A (es
Inventor
Stefani Stefania
Santagati Maria
Tiberi Licia
Original Assignee
Dmg Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmg Italia Srl filed Critical Dmg Italia Srl
Publication of MX2012011706A publication Critical patent/MX2012011706A/es
Publication of MX342226B publication Critical patent/MX342226B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a una nueva cepa microbiana de la especie Streptococcus salivarius para usarla en el tratamiento de procesos inflamatorios con o sin etiología infecciosa. Es otro objetivo de la presente invención las composiciones que comprenden dicha cepa, y sus usos.
MX2012011706A 2010-04-07 2011-04-07 Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio. MX342226B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM20100163 2010-04-07
PCT/IT2011/000104 WO2011125086A1 (en) 2010-04-07 2011-04-07 Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract

Publications (2)

Publication Number Publication Date
MX2012011706A MX2012011706A (es) 2013-03-08
MX342226B true MX342226B (es) 2016-09-21

Family

ID=42795606

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012011706A MX342226B (es) 2010-04-07 2011-04-07 Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio.

Country Status (18)

Country Link
US (1) US20130095044A1 (es)
EP (1) EP2555785B8 (es)
BR (1) BR112012025640A2 (es)
CA (1) CA2800514C (es)
CY (1) CY1117633T1 (es)
DK (1) DK2555785T3 (es)
ES (1) ES2573729T3 (es)
HR (1) HRP20160580T1 (es)
HU (1) HUE030227T2 (es)
IL (1) IL222333A (es)
ME (1) ME02448B (es)
MX (1) MX342226B (es)
PL (1) PL2555785T3 (es)
PT (1) PT2555785E (es)
RS (1) RS54837B1 (es)
SI (1) SI2555785T1 (es)
SM (2) SMP201200048B (es)
WO (1) WO2011125086A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9408785B2 (en) 2012-10-15 2016-08-09 L'oreal Hair styling compositions containing aqueous wax dispersions
US10626294B2 (en) 2012-10-15 2020-04-21 L'oreal Aqueous wax dispersions containing volatile solvents
US10413496B2 (en) 2012-10-15 2019-09-17 L'oreal Aqueous wax dispersions
US10561596B2 (en) 2014-04-11 2020-02-18 L'oreal Compositions and dispersions containing particles comprising a polymer
ES2761613T3 (es) 2014-10-28 2020-05-20 Dmg Italia Srl Barrera biológica con simeticona para su uso en el tratamiento de infecciones nasofaringotubáricas
EP3015110A1 (en) 2014-10-28 2016-05-04 D.M.G. Italia Srl Biological barrier with cystein for the use in the treatment of naso-pharyngo-tubal infections
WO2021201699A1 (en) * 2020-04-03 2021-10-07 Blis Technologies Limited Antiviral treatment comprising blis containing probiotic products
JP2023540973A (ja) 2020-09-04 2023-09-27 ユニバーシタット アントウェルペン 新規プロバイオティックストレプトコッカス・サリバリウス株とその用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776462A (en) * 1996-12-10 1998-07-07 Sage R&D, A Partnership Pogostemon cablin extract for inhibiting H. influenzae adhesion and treating otitis media or sore throat
RU2279481C2 (ru) 1999-10-12 2006-07-10 Блис Текнолоджис Лимитед Лантибиотик
DK1483366T3 (da) * 2002-02-22 2010-08-09 Blis Technologies Ltd Antimikrobiel sammensætning
WO2004072272A1 (en) 2003-02-14 2004-08-26 Blis Technologies Limited Bacterial compositions

Also Published As

Publication number Publication date
PL2555785T3 (pl) 2016-12-30
ME02448B (me) 2016-09-20
CY1117633T1 (el) 2017-04-26
EP2555785B1 (en) 2016-04-06
IL222333A (en) 2017-02-28
EP2555785B8 (en) 2016-07-13
CA2800514C (en) 2019-06-18
SI2555785T1 (sl) 2016-07-29
EP2555785A1 (en) 2013-02-13
HRP20160580T1 (hr) 2016-06-17
BR112012025640A2 (pt) 2016-06-28
IL222333A0 (en) 2012-12-31
PT2555785E (pt) 2016-06-08
SMT201600190B (it) 2016-08-31
DK2555785T3 (en) 2016-06-13
MX2012011706A (es) 2013-03-08
RS54837B1 (sr) 2016-10-31
SMAP201000048A (it) 2013-01-14
HUE030227T2 (en) 2017-05-29
SMP201200048B (it) 2013-07-09
WO2011125086A1 (en) 2011-10-13
CA2800514A1 (en) 2011-10-13
US20130095044A1 (en) 2013-04-18
ES2573729T3 (es) 2016-06-09

Similar Documents

Publication Publication Date Title
MX342226B (es) Uso de streptococcus salivarius en el tratamiento de infecciones cronicas del tracto respiratorio.
MX345762B (es) Compuestos antiinfecciosos.
HK1222130A1 (zh) 具有抗微生物活性的細菌菌株及包括所述菌株的生物控制組合物
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
CL2013001316A1 (es) Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.
WO2014145958A3 (en) Network-based microbial compositions and methods
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
EP3409666A3 (en) Seca inhibitors and methods of making and using thereof
MX346664B (es) Una composicion que comprende un agente antibiotico y un agente dispersante o un agente antiadhesivo.
MX2009008617A (es) Uso de antagonistas de interleucina-23 para el tratamiento de infeccion.
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
GB2482536B (en) Expression of antibody or a fragment thereof in lactobacillus
AU2012302022A8 (en) Antibacterial compounds and methods for use
PT2833899T (pt) Composições compreendendo coquetéis de fagos e uso das mesmas para o tratamento de infeções bacterianas
MX336260B (es) Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina.
RS54478B1 (en) LACTOBACILLUS PLANTARUM MCC1 DSM 23881 ISOLATED MICRO-ORGANISM AND ITS USE
WO2012019054A3 (en) Expression of antibody or a fragment thereof in lactobacillus
IN2012DN01414A (es)
EP3059303A4 (en) Bacterial strain of actinoplanes sp. and application thereof
IN2013MU03216A (es)
SI2683418T1 (sl) Produkti za vezavo bakterijskih toksinov in njihovo odstranjevanje pri zdravljenju lokalnih okužb in izdelava le-teh
AU2018257122A1 (en) Pharmaceutical composition comprising attenuated streptococcus pneumoniae strains and use thereof
JP2013516309A5 (es)
PL404948A1 (pl) Zastosowanie pinafide i chaetochromin
WO2013098413A3 (fr) Composition inhibitrice de croissance bactérienne et utilisation de cette composition

Legal Events

Date Code Title Description
FG Grant or registration